For: | Ntavatzikos A, Spathis A, Patapis P, Machairas N, Peros G, Konstantoudakis S, Leventakou D, Panayiotides IG, Karakitsos P, Koumarianou A. Integrating TYMS, KRAS and BRAF testing in patients with metastatic colorectal cancer. World J Gastroenterol 2017; 23(32): 5913-5924 [PMID: 28932083 DOI: 10.3748/wjg.v23.i32.5913] |
---|---|
URL: | https://www.wjgnet.com/1948-9366/full/v23/i32/5913.htm |
Number | Citing Articles |
1 |
Yassine Khalij, Imtinen Belaid, Sana Chouchane, Dorra Amor, Asma Omezzine, Nabila Ben rejeb, Slim ben Ahmed, Ali Bouslama. DPYDandTYMSpolymorphisms as predictors of 5 fluorouracil toxicity in colorectal cancer patients. Journal of Chemotherapy 2023; 35(5): 425 doi: 10.1080/1120009X.2022.2125736
|
2 |
G. Carlsson, A. Koumarianou, T.K. Guren, J. Haux, P. Katsaounis, N. Kentepozidis, P. Pfeiffer, M. Brændengen, D. Mavroudis, H. Taflin, L. Skintemo, R. Tell, C. Papadimitriou. A phase I/II study of arfolitixorin and 5-fluorouracil in combination with oxaliplatin (plus or minus bevacizumab) or irinotecan in metastatic colorectal cancer. ESMO Open 2022; 7(5): 100589 doi: 10.1016/j.esmoop.2022.100589
|
3 |
Charalampia Ioannou, Georgia Ragia, Ioanna Balgkouranidou, Nikolaos Xenidis, Kyriakos Amarantidis, Triantafyllia Koukaki, Eirini Biziota, Stylianos Kakolyris, Vangelis G Manolopoulos.
Gender-Dependent Association of
Tyms
-TSER Polymorphism With 5-Fluorouracil or Capecitabine-Based Chemotherapy Toxicity
. Pharmacogenomics 2021; 22(11): 669 doi: 10.2217/pgs-2021-0031
|
4 |
Shuai Li, Jingyuan Zhao, Linlin Lv, Deshi Dong. Identification and Validation of TYMS as a Potential Biomarker for Risk of Metastasis Development in Hepatocellular Carcinoma. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.762821
|
5 |
Li Guo, Yaodong Zhang, Zibo Yin, Yaya Ji, Guowei Yang, Bowen Qian, Sunjing Li, Jun Wang, Tingming Liang, Changxian Li, Xiangcheng Li. Screening and identification of genes associated with cell proliferation in cholangiocarcinoma. Aging 2020; 12(3): 2626 doi: 10.18632/aging.102766
|
6 |
Hui-Zhu Qiu, Ji Huang, Cheng-Cheng Xiang, Rong Li, Er-Dong Zuo, Yuan Zhang, Li Shan, Xu Cheng. Screening and Discovery of New Potential Biomarkers and Small Molecule Drugs for Cervical Cancer: A Bioinformatics Analysis. Technology in Cancer Research & Treatment 2020; 19 doi: 10.1177/1533033820980112
|
7 |
Sivasankari Ramadurai, Saurav Panicker, Satish Ramalingam. Cancer Genes: Volume 2. 2023; : 202 doi: 10.2174/9789815136500123020008
|
8 |
Mona Kamal Eldeeb, Mai Maher Abd-Elaziz Shoaib, Esraa Ahmed Abd-Elmonem, Hesham Mahmoud Sayd Saeed, Amira Mohammad Embaby, Ayman Mohamed Farouk, Radwa Mohammed Rashad. Genetic polymorphisms and gene expression of one-carbon metabolizing enzymes and their relation to breast cancer. Egyptian Journal of Medical Human Genetics 2022; 23(1) doi: 10.1186/s43042-022-00296-8
|
9 |
Miao Xu, Tianxiang Ouyang, Kaiyang Lv, Xiaorong Ma. Integrated WGCNA and PPI Network to Screen Hub Genes Signatures for Infantile Hemangioma. Frontiers in Genetics 2021; 11 doi: 10.3389/fgene.2020.614195
|
10 |
Juan Pablo Cayún, Leslie Carol Cerpa, Alicia Colombo, Dante Daniel Cáceres, José Luis Leal, Felipe Reyes, Carolina Gutiérrez-Cáceres, Susan Calfunao, Nelson Miguel Varela, Luis Abel Quiñones. Genetic Polymorphisms and Tumoral Mutational Profiles over Survival in Advanced Colorectal Cancer Patients: An Exploratory Study. Current Oncology 2024; 31(1): 274 doi: 10.3390/curroncol31010018
|
11 |
Anna Koumarianou, Ioannis Panayiotides, Iordanis Papadopoulos, George Peros, Georgia Vourli, Nikolaos Machairas, Paul Patapis, Aris Spathis, Anastasios Ntavatzikos. TYMS/KRAS/BRAF molecular profiling predicts survival following adjuvant chemotherapy in colorectal cancer. World Journal of Gastrointestinal Oncology 2019; 11(7): 551-566 doi: 10.4251/wjgo.v11.i7.551
|